Lantheus Holdings, Inc.
NASDAQ:LNTH · NASDAQ Global Market
+$1.01 today
Vol 0.99M · Avg 0.94M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+28.52%
Period High
$105.03
Period Low
$50.11
Latest
$103.86
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Praxis Precision Medicines, Inc.
NASDAQ:PRAX
$6.03B
Amneal Pharmaceuticals, Inc.
NASDAQ:AMRX
$5.25B
Hinge Health, Inc.
NYSE:HNGE
$5.20B
Indivior Pharmaceuticals Inc
NASDAQ:INDV
$4.83B
Crinetics Pharmaceuticals, Inc.
NASDAQ:CRNX
$3.81B
ACADIA Pharmaceuticals Inc.
NASDAQ:ACAD
$3.71B
Supernus Pharmaceuticals, Inc.
NASDAQ:SUPN
$2.55B
ADMA Biologics, Inc.
NASDAQ:ADMA
$1.97B
HUTCHMED (China) Limited
NASDAQ:HCM
$1.82B
Bausch Health Companies Inc.
NYSE:BHC
$1.75B
What is the latest LNTH filing?
The latest filing shown is SD dated May 29, 2026.
How many recent filings does LNTH have?
Intrinsic Alpha currently shows 20 recent filings for LNTH.
Explore More
Continue the stock analysis
Jump to another research area for this company.